Seroxo is a world-leading IVD company pioneering the development and commercialisation of a transformative technology. The LIT™, a 10-minute finger-prick blood test, is a patented breakthrough technology that assesses real-time, 3D neutrophil function with applications in cancer, sepsis and emergency triage.